Navigating uncertainty, unlocking capital, and funding growth in life sciences
The life sciences sector is facing one of its most complex capital environments in decades. While innovation continues at pace, access to funding has become more selective, timelines have extended, and investors are applying deeper scrutiny across pipelines, platforms, and leadership teams. Companies are expected to demonstrate capital efficiency, differentiated science, and a credible path to value earlier than ever before.
At the same time, capital has not disappeared, it has become strategic, global, and highly targeted.
The Capital Markets & Investment Strategies pillar at LSX World Congress is designed to help founders, executives, and investors understand how funding decisions are being made today, where capital is flowing, and how to position companies for success across private and public markets.
This pillar brings together venture capital firms, growth investors, public market experts, corporate venture teams, and financial advisors for in-depth discussions on funding strategies across the full company lifecycle.
What you'll walk away with:
Attendees leave this pillar with a clear, practical understanding of today’s investment landscape — and how to operate within it.
Founders and leadership teams gain insight into how investors assess risk, value, and long-term potential, enabling them to:
Build funding strategies aligned with realistic market conditions
Strengthen their equity story across science, data, and commercial rationale
Align development milestones with investor expectations
Identify the right type of capital at the right stage of growth
Avoid common fundraising pitfalls that delay or derail financing
Key session themes you can’t miss:
- Funding Strategies for Early and Growth-Stage Companies
Practical guidance on building resilient funding roadmaps in a more selective investment climate. - Private vs Public Markets
Exploring IPO readiness, crossover financing, and alternative routes to liquidity. - Global Investment & Cross-Border Deal Flow
Including perspectives on investment opportunities in high-growth markets such as Asia and China. - Corporate Venture and Strategic Capital
How corporates are deploying capital and partnering with innovative life science companies.
Investors benefit from deeper visibility into:
Emerging innovation trends across subsectors and geographies
How management teams are adapting strategies to capital constraints
Where compelling risk-adjusted opportunities are forming
How capital structures and partnerships are evolving
Above all, this pillar equips attendees to make smarter, more strategic capital decisions. Whether raising, deploying, or managing investment in life sciences.